![](https://endpts.com/wp-content/uploads/2023/02/opioid-feature-credit-Kathy-Wong.jpg)
Illustration: Assistant Editor Kathy Wong for Endpoints News
How Purdue's $272M addiction payout funded a new home for its discarded non-opioid research
Don Kyle spent more than 20 years working for Purdue Pharma, right through the US opioid epidemic that led to the company’s rise and eventual …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.